Catalyst Funds Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,698	Closed	-$25.5K	–	432
2025 Q1	$25.5K	Buy	16,698 +2,698	+19%	+$4.13K	0.01%	435
2024 Q4	$34.7K	Hold	14,000	–	–	0.01%	284
2024 Q3	$16.1K	Hold	14,000	–	–	﹤0.01%	1115
2024 Q2	$15.4K	Buy	+14,000	New	+$15.4K	﹤0.01%	771